Signet ring cell carcinoma of the ampulla of Vater: Immunophenotype and differentiation
Authors:
Open Access
- 11 July 2014
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 8 (4) , 1687-1692
Abstract
Signet ring cell carcinoma (SRC) of the ampulla of Vater is extremely rare and the histogenesis remains unknown. In the present study, to investigate the immunohistochemical phenotypes, discuss the histological origin and evaluate the correlation between the immunohistochemical phenotypes and survival of ampullary SRC patients, a retrospective review was conducted. This included all ampullary carcinoma patients treated at The First Affiliated Hospital, College of Medicine, Zhejiang University, and was performed over a five‑year period between 2008 and 2012. Eight resected ampullary SRC specimens were examined histopathologically and immunohistochemically, using cytokeratin (CK) and mucin (MUC) immunohistochemical phenotypes. Of all 162 patients with ampullary lesions, eight cases (4.9%) of ampullary SRC were identified. Immunohistochemical analyses of the eight cases revealed the positive expression of CK7 in five, CK19 in seven, CK20 in one, MUC1 in five, MUC2 in three, caudal‑related homeobox transcription factor 2 in one, MUC5AC in seven and MUC6 in four of the eight cases, while loss of E‑cadherin and β‑catenin was observed in four of the eight cases. According to immunohistochemical classification, ampullary SRC can be classified into four subtypes: Intestinal (I), pancreatobiliary (PB), gastric and mixed types (composed of I mucosa lining and PB epithelium). Patients with the I‑type ampullary SRC demonstrated a more favorable prognosis than that of patients with the PB‑type ampullary SRC. Additionally, patients with ampullary SRC of I or PB type with gastric differentiation may have a worse prognosis than others. The coexpression of the E‑cadherin/β‑catenin complex may also indicate poor prognosis in PB‑type ampullary SRC. In conclusion, the clinical five‑year follow‑up of the patients with pure SRC was more positive than that of those with I‑, PB‑, gastric‑ or mixed‑type ampullary SRC. The coexpression of the E-cadherin/β-catenin complex may present a poor prognosis in the PB type of ampullary SRC.Keywords
This publication has 22 references indexed in Scilit:
- Signet Ring Cell Carcinoma of the Vater's Ampulla: A Very Rare MalignancyCase Reports in Oncological Medicine, 2012
- Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosisDiagnostic Pathology, 2010
- Lymph Node Involvement and Not the Histophatologic Subtype Is Correlated with Outcome After Resection of Adenocarcinoma of the Ampulla of VaterJournal of Gastrointestinal Surgery, 2010
- Loss of E‐cadherin and β‐catenin is correlated with poor prognosis of ampullary neoplasmsJournal of Surgical Oncology, 2010
- Intraductal tubular adenoma (pyloric gland‐type) of the pancreas: a reappraisal and possible relationship with gastric‐type intraductal papillary mucinous neoplasmHistopathology, 2009
- Signet-ring cell carcinoma of ampulla of Vater: Contrast-enhanced ultrasound findingsWorld Journal of Gastroenterology, 2009
- Signet-Ring Cell Carcinoma of the Ampulla of Vater: Report of a CaseSurgery Today, 2007
- Signet Ring Cells in Gastric Carcinomas Are Derived from Neuroendocrine CellsJournal of Histochemistry & Cytochemistry, 2006
- Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomasVirchows Archiv, 2004
- Signet-Ring Cell Carcinoma of the Ampulla of Vater: Report of a CaseSurgery Today, 2003